Lobbying registrant · LDA.gov number 286096
THE MCMANUS GROUP
24 reportsConfirmed from the official record
THE MCMANUS GROUP is named as the registrant in 24 lobbying reports we hold for 2026-Q2, for 24 clients. 0 reports of 24 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| ACESSO BIOLOGICS | 2026-Q2: $60,000 in income | 1 |
| AMBULATORY SURGERY CENTER ASSOCIATION | 2026-Q2: $60,000 in income | 1 |
| AMERICAN OCCUPATIONAL THERAPY ASSOCIATION | 2026-Q2: $40,000 in income | 1 |
| AMGEN | 2026-Q2: $60,000 in income | 1 |
| ARDELYX | 2026-Q2: $60,000 in income | 1 |
| BIOWOUND SOLUTIONS | 2026-Q2: $50,000 in income | 1 |
| BRISTOL-MYERS SQUIBB | 2026-Q2: $80,000 in income | 1 |
| DENDREON PHARMACEUTICALS LLC | 2026-Q2: $30,000 in income | 1 |
| FULCRUM THERAPEUTICS | 2026-Q2: $60,000 in income | 1 |
| GENENTECH | 2026-Q2: $50,000 in income | 1 |
| GILEAD SCIENCES, INC. | 2026-Q2: $60,000 in income | 1 |
| GRAIL, INC. | 2026-Q2: $50,000 in income | 1 |
| INFUSION PROVIDERS ALLIANCE | 2026-Q2: $90,000 in income | 1 |
| LARGE UROLOGY GROUP PRACTICE ASSOCIATION | 2026-Q2: $90,000 in income | 1 |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | 2026-Q2: $30,000 in income | 1 |
| NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) | 2026-Q2: $60,000 in income | 1 |
| OWLET | 2026-Q2: $30,000 in income | 1 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2026-Q2: $60,000 in income | 1 |
| ROCHE DIAGNOSTICS | 2026-Q2: $40,000 in income | 1 |
| VENTURE MEDICAL | 2026-Q2: $30,000 in income | 1 |
| VIALASE INC. | 2026-Q2: $50,000 in income | 1 |
| VIVEX BIOLOGICS | 2026-Q2: $50,000 in income | 1 |
| WEX HEALTH | 2026-Q2: $50,000 in income | 1 |
| ZIMMER BIOMET | 2026-Q2: $50,000 in income | 1 |
Lobbyists named in these reports
- ABIGAIL SMITH · 9 reports
- ALEX WHALEN · 17 reports
- JOHN MCMANUS · 24 reports · earlier government job reported
- MARY GRACE DARCEY · 5 reports
Bills named, and how the House and the Senate voted
42 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 548HSA Modernization Act | Introduced | No recorded vote in our record |
| H.R. 879Medicare Patient Access and Practice Stabilization Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 919Chronic Disease Flexible Coverage Act | Passed the House | No recorded vote in our record |
| H.R. 1157ACCESS Act | Introduced | No recorded vote in our record |
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 1614To amend title XVIII of the Social Security Act to expand practitioners eligible to furnish telehealth services under the Medicare program. | Introduced | No recorded vote in our record |
| H.R. 1796Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 2013Medicare Home Health Accessibility Act | Introduced | No recorded vote in our record |
| H.R. 2168BO’s Act | Introduced | No recorded vote in our record |
| H.R. 2474Expanding Appalachia’s Broadband Access Act | Passed the House | No recorded vote in our record |
| H.R. 2484Seniors’ Access to Critical Medications Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 3006To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center. | Introduced | No recorded vote in our record |
| H.R. 3134Emergency Care Improvement Act | Introduced | No recorded vote in our record |
| H.R. 4037Occupational Therapy Mental Health Parity Act. | Introduced | No recorded vote in our record |
| H.R. 4206CONNECT for Health Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act | Introduced | No recorded vote in our record |
| H.R. 4710No Surprises Act Enforcement Act | Introduced | No recorded vote in our record |
| H.R. 5269RESULTS Act | Introduced | No recorded vote in our record |
| H.R. 5343Ensuring Patient Access to Critical Breakthrough Products Act | Introduced | No recorded vote in our record |
| H.R. 5463Choice Arrangement | Introduced | No recorded vote in our record |
| H.R. 5582Patients Deserve Price Tags Act | Introduced | No recorded vote in our record |
| H.R. 5768Skin Substitute Access and Payment Reform Act | Introduced | No recorded vote in our record |
| H.R. 6852Advanced Wound Care and Regenerative Medicine Access and Reform Act | Introduced | No recorded vote in our record |
| H.R. 8091Outpatient Surgery Access Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 8163Provider Reimbursement Stability Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 8413SECURE Data Act | Introduced | No recorded vote in our record |
| H.R. 9260Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| H.R. 9393Lower Costs, More Transparency Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 9504Tax Exempt Hospital Transparency Act | Introduced | No recorded vote in our record |
| S. 735Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 | Introduced | No recorded vote in our record |
| S. 832EPIC Act of 2025 | Introduced | No recorded vote in our record |
| S. 1261CONNECT for Health Act of 2025 | Introduced | No recorded vote in our record |
| S. 1629Same Care, Lower Cost Act | Introduced | No recorded vote in our record |
| S. 1640Medicare Patient Access and Practice Stabilization Act of 2025 | Introduced | No recorded vote in our record |
| S. 1717Ensuring Patient Access to Critical Breakthrough Products Act of 2025 | Introduced | No recorded vote in our record |
| S. 1776Medicare Beneficiary Co-Pay Fairness Act | Introduced | No recorded vote in our record |
| S. 2355Patients Deserve Price Tags Act | Reported by committee | No recorded vote in our record |
| S. 2420No Surprises Act Enforcement Act | Introduced | No recorded vote in our record |
| S. 2561Skin Substitute Access and Payment Reform Act of 2025 | Introduced | No recorded vote in our record |
| S. 2847Occupational Therapy Mental Health Parity Act | Introduced | No recorded vote in our record |
| S. 2875CHOICE Act | Introduced | No recorded vote in our record |
| S. 3712BO’s Act | Introduced | No recorded vote in our record |
Issues named: Medicare/Medicaid (22), Health Issues (13), Taxation/Internal Revenue Code (4), Trade (domestic/foreign) (2), Budget/Appropriations (1), Veterans (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| ZIMMER BIOMETMedicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| WEX HEALTHMedicare/Medicaid, Taxation/Internal Revenue Code | 2nd Quarter - Report | The report on LDA.gov | |
| VIVEX BIOLOGICSHealth Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| VIALASE INC.Health Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| VENTURE MEDICALMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| ROCHE DIAGNOSTICSMedicare/Medicaid, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAMedicare/Medicaid, Health Issues, Taxation/Internal Revenue Code | 2nd Quarter - Report | The report on LDA.gov | |
| OWLETHealth Issues, Budget/Appropriations | 2nd Quarter - Report | The report on LDA.gov | |
| NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC)Health Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATIONMedicare/Medicaid, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| LARGE UROLOGY GROUP PRACTICE ASSOCIATIONMedicare/Medicaid, Health Issues, Taxation/Internal Revenue Code | 2nd Quarter - Report | The report on LDA.gov | |
| INFUSION PROVIDERS ALLIANCEMedicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| GRAIL, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| GILEAD SCIENCES, INC.Medicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| GENENTECHMedicare/Medicaid, Health Issues, Taxation/Internal Revenue Code | 2nd Quarter - Report | The report on LDA.gov | |
| FULCRUM THERAPEUTICSHealth Issues | 2nd Quarter - Termination | The report on LDA.gov | |
| DENDREON PHARMACEUTICALS LLCMedicare/Medicaid, Veterans | 2nd Quarter - Report | The report on LDA.gov | |
| BRISTOL-MYERS SQUIBBMedicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| BIOWOUND SOLUTIONSMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| AMBULATORY SURGERY CENTER ASSOCIATIONMedicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| AMERICAN OCCUPATIONAL THERAPY ASSOCIATIONMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| ARDELYXMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| AMGENMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| ACESSO BIOLOGICSMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.